Skip to content

ES PHARMA

Active Private limited companyfounded 2024active for 2 yearsZandputlaan 38, 2400 MolKBO/BCE: BE 1009.079.320

Board

1 director, since incorporation
Director (not named in the articles)
since 03-05-2024 term without a fixed end
listed in the 2025 annual accounts, filed on 03-06-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 07-05-2024

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
SMET Emma Olga Simonna
Director (not named in the articles)
Board
Mandates as a list
  • SMET Emma Olga Simonna
    • Director (not named in the articles), from 03-05-2024 to date

Control

This company
ES PHARMA
Equity €46,820
Profit €32,777 in 2025

Capital

Contribution
€3,000
Shares
300
Contribution per share
€10
Equity per share
€156 in 2025
Source
2025 annual accounts

Articles of association

deed of 07-05-2024 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Helft overdrager,helft koper(s) naar evenredigheid aantal, elke overdracht onder levenden,ten bezwarende of kosteloze titel,vrijwillig of…”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Fourth Saturday of May at 20:00

Shareholders

At incorporation deed of 07-05-2024 ↗

Next steps